A Systems Approach Identifies Key Regulators of HPV-Positive Cervical Cancer
Open Access
- 14 May 2020
- preprint content
- other
- Published by Cold Spring Harbor Laboratory
Abstract
Cervical cancer has remained the most prevalent and lethal malignancy among women worldwide and accounted for over 250,000 deaths in 2019. Nearly ninety-five per cent of cervical cancer cases are associated with persistent infection with high-risk Human Papillomavirus (HPV), and seventy per cent of these are associated with viral integration in the host genome. HPV-infection imparts specific changes in the regulatory network of infected cancer cells that are of diagnostic, prognostic and importance. Here, we conducted a systems-level analysis of the regulatory network changes, and the associated regulatory proteins thereof, in HPV-positive cervical cancer. We applied functional pathway analysis to show that HPV-positive cancers are characterised by perturbations of numerous cellular processes, predominantly in those linked to the cell cycle, mitosis, cytokine and immune cell signalling. Using computational predictions, we revealed that HPV-positive cervical cancers are regulated by transcription factors including, SOX2, E2F, NANOG, OCT4, and MYC, which control various processes such as the renewal of cancer stem cells, and the proliferation and differentiation of tumour cells. Through the analysis of upstream regulatory kinases, we identified the mitogen-activated protein kinases; among others, MAPK1, MAPK3 and MAPK8, and the cyclin-dependent kinases; among others, CDK1, CDK2 and CDK4, as the key kinases that control the biological processes in HPV-positive cervical cancers. Taken together, we uncover a landscape of the key regulatory pathways and proteins in HPV-positive cervical cancers, all of which may provide attractive drug targets for future therapeutics.Keywords
This publication has 83 references indexed in Scilit:
- Cervical cancerThe Lancet, 2019
- Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warningJournal of Medical Genetics, 2018
- Evidence of EBV infection in lymphomas diagnosed in Lusaka, ZambiaPan African Medical Journal, 2018
- The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic TargetsTrends in Microbiology, 2017
- Cervical cancer: A global health crisisCancer, 2017
- Cervical Cancer: Prevention and Early DetectionSeminars in Oncology Nursing, 2017
- Integrated genomic and molecular characterization of cervical cancerNature, 2017
- Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanismNature Genetics, 2015
- Landscape of genomic alterations in cervical carcinomasNature, 2013
- p53 and Rb: their cellular rolesCurrent Opinion in Cell Biology, 1994